| Name | Title | Contact Details |
|---|---|---|
Mark Finkle |
VP of Engineering (Productivity & Developer Program) | Profile |
The Greater Hudson Valley Health System is dedicated to developing specialty services, medical programs and needed healthcare services that allow residents to remain close to home to receive quality care.
JK Associates is a Conshohocken, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Care First EMS is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The largest health insurer in the state of Kansas. As a mutual insurance company, BCBSKS is owned by its policyholders. Its board of directors consists of Kansans from different areas of the state, 16 policyholders who bring to the table practical experience in business, medicine, hospital administration and education. Day-to-day operations are directed by a nine-person steering committee under the guidance of the company’s president/CEO. Customers and health care professionals have a voice in company activities through numerous advisory and liaison committees, as well as focus groups and surveys. BCBSKS is a financially secure, billion dollar company that contributes to the Kansas economy in several ways. The company surpasses $1 billion in annual claims payments to health care providers and members and contributes more than $140 million a year to the economy through payroll and taxes. The company's headquarters are located in Topeka, KS. Nearly 1,400 employees work in the company's various office locations in Topeka. In addition, about 110 employees work in offices in Dodge City, Garden City, Hays, Hutchinson, Independence, Lawrence, Manhattan, Pittsburg, Salina and Wichita. BCBSKS is a member of the Blue Cross Blue Shield Association headquartered in Chicago. There are 36 Blue Cross and Blue Shield Plans throughout the United States. Each Plan is separate and independent but all Plans cooperate with other Blue Cross and Blue Shield Plans in the exchange of ideas, processing of claims and providing inter-plan services to customers.
The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany. We are an entrepreneurial specialist delivering true benefits to patients. By sustainably investing in research and development above the industrial average, we are committing to innovation in order to treat unmet medical needs and bring value-adding products to markets. Grünenthal is a fully integrated research & development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients.